Resource Library
Showing 1 to 10 of 206 results
You or your loved one has been diagnosed with chronic myeloid leukemia (CML).This booklet was designed to answer some questions you may have about chronic myeloid leukemia (CML). It summarizes what CML is and its phases, as well as treatment options available in Canada and their side effects.
CML is a rare type of leukemia (about 15% of all new cases of leukemia are CML) that occurs when a person has a Philadelphia chromosome or another mutation which expresses a new gene (BCR-ABL) inside certain blood cells, causing the bone marrow cells to make too many white blood cells. The Philadelphia chromosome is present in 95% of people with CML, but it…
Graft vs Host Disease, known as GvHD, is a side effect of a life saving procedure. People who undergo an allogeneic stem cell transplant - when a donor's stem cells are transplanted into the recipient - can experience either acute or chronic GvHD. In this podcast, listen to blood cancer survivor Libby Goszer, who describes her experience living with…
GvHD is a serious health complication that can result from an allogeneic stem cell transplant. It can happen when donor cells (graft) mistakenly attack the transplant recipient’s (host) tissue and cells.
There are various treatments, depending on whether you have acute or chronic GvHD. Acute GvHD which usually develops within 100 days of an allogeneic stem cell transplant, and chronic GvHD (cGvHD), which develops more than 100 days after the transplant.
Learn how to care for skin, nails, hair, and mouth during and after cancer treatments.
You or your loved one has been diagnosed with a type of blood cancer. Cancer treatment can be complex, with different types of treatment options available for some blood cancers. What are they and how do they work? This fact sheet will help you Learn about the different treatment options available, Understand each type of treatment and how it can help,…
Watch this 1-hour recorded webcast by Dr. Heather Leitch as she discusses myelodysplastic syndromes (MDS), a group of cancers of the blood and bone marrow.
Dr. Leitch is a hematologist at St. Paul’s Hospital in Vancouver, Canada and Clinical Professor in the Department of Medicine, University of British Columbia. Her clinical and research interests…
Dr. Leitch is a hematologist at St. Paul’s Hospital in Vancouver, Canada and Clinical Professor in the Department of Medicine, University of British Columbia. Her clinical and research interests…
In this 1-hour recorded webcast, hematologist-oncologist at the Princess Margaret Cancer Centre in Toronto, and DLBCL researcher, Dr. John Kuruvilla, discusses diagnosis and approach to managing and treating DLBCL, the most commonly diagnosed subtype of non-Hodgkin lymphoma.
It may be the first time you've talked about your blood cancer, since your diagnosis, with anyone outside immediate family, or it may be after years of living with cancer... Either way, the LLSC community services lead in your region is ready to listen and support you in any way you need. Geoffrey Molle, one of those leads, talks about the confidential…